Fort Washington Investment Advisors Inc. OH Buys 758 Shares of Cardinal Health, Inc. $CAH

Fort Washington Investment Advisors Inc. OH boosted its stake in Cardinal Health, Inc. (NYSE:CAH) by 6.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,739 shares of the company’s stock after acquiring an additional 758 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Cardinal Health were worth $2,140,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. JPMorgan Chase & Co. boosted its stake in shares of Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after purchasing an additional 1,193,983 shares during the last quarter. Northern Trust Corp boosted its position in Cardinal Health by 3.5% during the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock valued at $433,012,000 after acquiring an additional 105,154 shares during the last quarter. Wellington Management Group LLP boosted its position in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after acquiring an additional 2,249,241 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Cardinal Health by 3.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company’s stock valued at $227,877,000 after purchasing an additional 52,714 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Cardinal Health by 0.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock valued at $171,749,000 after purchasing an additional 7,940 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on CAH shares. Wells Fargo & Company restated an “overweight” rating and set a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Bank of America increased their price target on Cardinal Health from $165.00 to $170.00 and gave the stock a “buy” rating in a report on Tuesday, June 10th. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Robert W. Baird increased their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $165.93.

Insider Activity at Cardinal Health

In other Cardinal Health news, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the transaction, the insider owned 15,431 shares of the company’s stock, valued at $2,298,293.14. This trade represents a 64.59% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer directly owned 26,085 shares in the company, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their position. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock valued at $40,489,525 over the last three months. Insiders own 0.12% of the company’s stock.

Cardinal Health Stock Up 0.7%

CAH stock opened at $154.79 on Tuesday. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44. The stock’s 50 day moving average is $152.12 and its 200-day moving average is $149.79. The firm has a market capitalization of $36.78 billion, a PE ratio of 24.00, a P/E/G ratio of 1.30 and a beta of 0.73.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. During the same quarter last year, the company earned $1.84 earnings per share. The company’s revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.